ResQ Medical
Empowering Mothers Against Postpartum Hemorrhage
Company Overview
Snapshot
Founded in August 2022 by Itamar Dach and Amnon Weichselbaum, ResQ Medical operates with 1–10 employees. The company has raised $800,000 across three funding rounds. In August 2022, ResQ Medical secured Seed funding from Youdim Pharmaceuticals.
Business overview
ResQ Medical is a Health Tech & Life Sciences company focused on developing medical devices to address Postpartum Hemorrhage (PPH). The company's core product, ALMA, is designed to support natural uterine contraction to stop bleeding, offering an alternative to existing balloon-based treatments. ResQ Medical serves the healthcare industry, specifically targeting providers in gynecology and women's health, with a focus on improving maternal care during delivery.
Log in to access full profile ›Company Intelligence Q&A
- What is ResQ Medical's primary focus?
- ResQ Medical is developing a cutting-edge device to treat Postpartum Hemorrhage (PPH), aiming to become an essential tool in delivery rooms and the first choice for PPH treatment.
- When was ResQ Medical founded?
- ResQ Medical was founded in August 2022.
- Who are the founders of ResQ Medical?
- ResQ Medical was founded by Itamar Dach and Amnon Weichselbaum.
- What is the name of ResQ Medical's core product?
- ResQ Medical is developing ALMA, a device designed to support the natural contraction of the uterus to stop bleeding in cases of Postpartum Hemorrhage.
- Which investor participated in ResQ Medical's Seed funding round?
- In August 2022, ResQ Medical secured Seed funding from Youdim Pharmaceuticals. The company was also incubated by Youdim Pharmaceuticals.